Literature DB >> 16763785

Activation of Bad trafficking is involved in the BCR-mediated apoptosis of immature B cells.

E Malissein1, M Verdier, M H Ratinaud, D Troutaud.   

Abstract

The activity of Bad, a pro-apoptotic protein, is regulated by reversible phosphorylation. Moreover, sequestration of Bad within subcellular compartments may be a new mechanism of apoptosis regulation. In this study, we report that Bad interacts with 14-3-3 protein in WEHI-231 immature B cells. This association is disrupted following BCR stimulation in correlation with Bad translocation to mitochondria and apoptosis. Confocal microscopy was further used to examine the co-localization of Bad with lipid rafts in WEHI-231 and murineex vivoB cells. Bad was found colocalized to lipid rafts in freshly isolated mature B lymphocytes, in contrast to immature cells. Finally, co-immunoprecipitation experiments performed on WEHI-231 B cells revealed that PP1alpha interacts with Bcl-2 and Bad, and dissociation of the complex was found correlated with appearance of apoptosis. Bcl-2 seemed to be required to assemble the complex which may regulate Bad phosphorylation status and consequently cell survival. Collectively, present data outline the role of Bad trafficking in the BCR-mediated apoptosis and suggest that differences in intracellular Bad trafficking may be involved in the differential outcome of BCR signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763785     DOI: 10.1007/s10495-006-6713-7

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  2 in total

1.  Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action.

Authors:  Zhengxing Qu; David M Goldenberg; Thomas M Cardillo; Victoria Shi; Hans J Hansen; Chien-Hsing Chang
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

2.  Prolactin Rescues Immature B-Cells from Apoptosis Induced by B-Cell Receptor Cross-Linking.

Authors:  Rocio Flores-Fernández; Francisco Blanco-Favela; Ezequiel M Fuentes-Pananá; Luis Chávez-Sánchez; Patricia Gorocica-Rosete; Alberto Pizaña-Venegas; Adriana Karina Chávez-Rueda
Journal:  J Immunol Res       Date:  2016-05-24       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.